إعلان
إعلان
FBLG
FibroBiologics, Inc. Common Stock
0.33
USDبرعاية
-0.01
-3.46%
٠٨ يناير, ١٥:٥٦ UTC -5
مغلق
بعد الإغلاق
0.32
-0.01
-2.71%
تقارير أرباح FBLG
النسبة الإيجابية المفاجئة
FBLG تفوق 3 من 6 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.09
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-30.77%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
FibroBiologics, Inc. Common Stock earnings per share and revenue
On ٣١ أكتوبر ٢٠٢٥, FBLG reported earnings of -0.13 USD per share (EPS) for Q3 25, missing the estimate of -0.10 USD, resulting in a -18.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.09 USD, with revenue projected to reach -- USD, implying an نقصان of -30.77% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were FibroBiologics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, FibroBiologics, Inc. Common Stock reported EPS of -$0.13, missing estimates by -18.51%, and revenue of $0.00, 0% as expectations.
How did the market react to FibroBiologics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.33%, changed from $0.39 before the earnings release to $0.39 the day after.
When is FibroBiologics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for FibroBiologics, Inc. Common Stock's next earnings report?
Based on 6
المحللين, FibroBiologics, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان